TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway

BACKGROUND: Breast cancer (BC) is the most common malignant tumor among women worldwide. Tissue transglutaminase 2 (TG2) has been reported as a major player across several types of cancer. However, the effects of TG2 in breast cancer are less known. METHODS: The expression of TG2 in patients with BC...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Dahai, Xu, Ning, Sun, Liang, Yang, Zhaoying, He, Miao, Li, Youjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724448/
https://www.ncbi.nlm.nih.gov/pubmed/36471278
http://dx.doi.org/10.1186/s12885-022-10364-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724448/
https://www.ncbi.nlm.nih.gov/pubmed/36471278
http://dx.doi.org/10.1186/s12885-022-10364-2

Ejemplares similares